Saturday 17 October 2026 Export JAZZ’s income statement to Excel — free account

Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals PLC’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 4.88% from fiscal 2024. In the quarter to June 2026, revenue grew 15.6%, EPS grew 126.0%, free cash flow grew 141.0% and total debt fell 18.9%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

210.05 4.37 −2.04%

Follow JAZZ

Alert me

Market cap: $13.9B
P/E: 13.8×
Fwd P/E: 17.3×
Dividend yield: —
F-score: 5/9
Altman Z: 1.37
Beneish M: −3.03
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	15.80	410.98	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	3.31	2.64	2.43	1.92
P/FCF ratio Full definition →	10.75	37.30	32.79	21.00
P/Operating CF Full definition →	36.64	28.67	28.60	16.85
P/B ratio Full definition →	3.17	2.58	2.40	2.02
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	3.78	3.20	3.11	2.72
EV/EBITDA Full definition →	10.76	21.01	49.93	59.08
EV/Operating CF Full definition →	10.46	10.63	9.80	8.13
EV/FCF Full definition →	12.27	45.21	42.02	29.70
Quick Ratio Full definition →	1.38	1.65	1.46	1.24
Current Ratio Full definition →	1.78	2.04	1.86	1.65
Net Debt/EBITDA Full definition →	5.04	4.79	6.72	14.06
Debt/Assets Full definition →	39.27%	45.15%	45.96%	47.21%
Debt/Equity Full definition →	0.91	1.18	1.24	1.35
Asset Turnover Full definition →	0.42	0.38	0.36	0.35
Operating CF/Net income Full definition →	2.16	1.39	1.78	1.89
Capex/Depreciation Full definition →	(0.53)	(0.11)	(0.23)	(0.49)
Interest Coverage Full definition →	6.69	8.44	5.61	1.18
Research and Development Expense of Revenue Full definition →	17.17%	18.34%	17.86%	17.60%
Selling, General and Administrative Expense of Revenue Full definition →	32.21%	33.00%	33.91%	47.12%
Intangible Assets out of Total Assets Full definition →	0.53	0.51	0.54	0.56
Share Based Compensation of Revenue Full definition →	6.07%	6.97%	5.91%	7.82%
Graham Net Nets Full definition →	(0.15)	(0.23)	(0.31)	(0.46)
Graham Number Full definition →	161.46	27.53	0.00	0.00
Earnings Yield Full definition →	6.33%	0.24%	(3.41%)	(4.52%)
Free Cash Flow Yield Full definition →	9.30%	2.68%	3.05%	4.76%
Revenue per Share Full definition →	19.12	17.27	19.65	18.55
Operating CF per Share Full definition →	6.58	6.59	5.94	7.82
Capex per Share Full definition →	(1.50)	(0.32)	(0.69)	(1.44)
Free Cash Flow per Share Full definition →	5.07	6.28	5.26	6.38
Cash per Share Full definition →	34.81	46.43	40.04	33.71
Shareholders Equity per Share Full definition →	75.98	73.22	70.82	65.23
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	75.98	73.22	70.82	65.23
Free Cash Flow Full definition →	320.60	388.50	320.46	386.98
Working Capital Full definition →	1,737.40	2,336.50	1,923.50	1,481.78
Capital Expenditures Full definition →	(95.10)	(19.70)	(42.06)	(87.68)
Net Current Asset Value Full definition →	(2,311.00)	(2,744.20)	(3,174.70)	(3,641.58)
EV/EBIT Full definition →	19.38	0.00	0.00	0.00
Capex to Sales Full definition →	0.08	0.02	0.04	0.08
Price to Operating Income Full definition →	16.98	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	797.45	744.65	773.73	744.00
Average Payables Full definition →	108.93	97.97	99.98	118.83
Average Inventory Full definition →	473.99	465.14	448.72	511.21
Average Assets Full definition →	11,012.52	11,697.14	11,835.78	11,806.11
Average Common Equity Full definition →	4,254.03	4,353.60	4,206.18	4,065.05

Fold the line items

Columns are period end dates

Stockrow Weekly